遗传性血管性水肿诊疗路径皮肤科专家共识（2025版）

doi:10.35541/cjd.20240676

中华皮肤科杂志 ›› 2025, Vol. 58 ›› Issue (6): 497-502.doi: 10.35541/cjd.20240676

遗传性血管性水肿诊疗路径皮肤科专家共识（2025版）

中华医学会皮肤性病学分会中国医师协会皮肤科医师分会

中华医学会皮肤性病学分会中国医师协会皮肤科医师分会

收稿日期:2024-12-11 修回日期:2025-03-24 发布日期:2025-06-03
通讯作者: 肖汀;高兴华 E-mail:cmuxt@126.com; gaobarry@hotmail.com
基金资助:
国家自然科学基金（82373487）

Recommendations for the diagnosis and treatment pathway for hereditary angioedema:a dermatology expert group consensus （2025 edition）

Chinese Society of Dermatology; China Dermatologist Association

Chinese Society of Dermatology; China Dermatologist Association

Received:2024-12-11 Revised:2025-03-24 Published:2025-06-03
Contact: Xiao Ting; Gao Xinghua E-mail:cmuxt@126.com; gaobarry@hotmail.com
Supported by:
National Natural Science Foundation of China（82373487）

摘要/Abstract

摘要： 【摘要】遗传性血管性水肿（HAE）是由缓激肽介导、以皮肤和/或黏膜水肿为主要表现的罕见常染色体显性遗传病，主要累及皮肤、上呼吸道和消化道，喉头水肿死亡率高。提升皮肤科医生诊断和治疗HAE的水平有助于及早发现并改善HAE患者的预后。我国19位皮肤科专家根据近年国内外高质量文献和专家经验，经多次讨论制订了本共识，期望为临床医生提供规范化的HAE诊断和治疗路径。

关键词: 血管水肿, 遗传性, 临床路径, 皮肤病学, 专家共识

Abstract: 【Abstract】 Hereditary angioedema （HAE） is a rare autosomal dominant hereditary disorder mediated by bradykinin and characterized by recurrent skin and/or mucosal edema. HAE attacks commonly affect the skin, upper respiratory tract and gastrointestinal tract. Laryngeal edema in HAE patients carries a high mortality rate. Enhancing dermatologists′ ability to diagnose and treat HAE can significantly improve patient outcomes. This consensus was developed based on Chinese and international high-quality literature in recent years and clinical experience of 19 dermatological experts in China, aiming to provide standardized diagnosis and treatment pathway for HAE.

Key words: Angioedemas, hereditary, Critical pathways, Dermatology, Consensus

中华医学会皮肤性病学分会中国医师协会皮肤科医师分会. 遗传性血管性水肿诊疗路径皮肤科专家共识（2025版）[J]. 中华皮肤科杂志, 2025,58(6):497-502. doi:10.35541/cjd.20240676

Chinese Society of Dermatology, China Dermatologist Association. Recommendations for the diagnosis and treatment pathway for hereditary angioedema:a dermatology expert group consensus （2025 edition）[J]. Chinese Journal of Dermatology, 2025, 58(6): 497-502.doi:10.35541/cjd.20240676

参考文献 40

［1］	Sarkar A, Nwagwu C, Craig T. Hereditary angioedema: a disease often misdiagnosed and mistreated［J］. Prim Care, 2023,50（2）:295⁃303. doi: 10.1016/j.pop.2022.11.005.
［2］	Magerl M, Gothe H, Krupka S, et al. A Germany⁃wide survey study on the patient journey of patients with hereditary angioedema［J］. Orphanet J Rare Dis, 2020,15（1）:221. doi: 10.1186/s13023⁃020⁃01506⁃5.
［3］	Zanichelli A, Magerl M, Longhurst H, et al. Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe［J］. Allergy Asthma Clin Immunol, 2013,9（1）:29. doi: 10.1186/1710⁃1492⁃9⁃29.
［4］	Banerji A, Busse P, Christiansen SC, et al. Current state of hereditary angioedema management: a patient survey［J］. Allergy Asthma Proc, 2015,36（3）:213⁃217. doi: 10.2500/aap.2015.36. 3824.
［5］	Lunn ML, Santos CB, Craig TJ. Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients?［J］. Ann Allergy Asthma Immunol, 2010,104（3）:211⁃214. doi: 10.1016/j.anai.2009.12.004.
［6］	Giavina⁃Bianchi P, Vivolo Aun M, Giavina⁃Bianchi M, et al. Hereditary angioedema classification: expanding knowledge by genotyping and endotyping［J］. World Allergy Organ J, 2024,17（5）:100906. doi: 10.1016/j.waojou.2024.100906.
［7］	Maurer M, Magerl M, Betschel S, et al. The international WAO/EAACI guideline for the management of hereditary angioedema⁃the 2021 revision and update［J］. Allergy, 2022,77（7）:1961⁃1990. doi: 10.1111/all.15214.
［8］	Davis AE 3rd. Mechanism of angioedema in first complement component inhibitor deficiency［J］. Immunol Allergy Clin North Am, 2006,26（4）:633⁃651. doi: 10.1016/j.iac.2006.08.003.
［9］	Ding L, Zhang MJ, Rao GW. Summary and future of medicine for hereditary angioedema［J］. Drug Discov Today, 2024,29（3）:103890. doi: 10.1016/j.drudis.2024.103890.
［10］	Bork K, Wulff K, Witzke G, et al. Treatment of patients with hereditary angioedema with the c.988A>G （p.Lys330Glu） variant in the plasminogen gene［J］. Orphanet J Rare Dis, 2020,15（1）:52. doi: 10.1186/s13023⁃020⁃1334⁃8.
［11］	Vincent D, Parsopoulou F, Martin L, et al. Hereditary angioedema with normal C1 inhibitor associated with carboxypeptidase N deficiency［J］. J Allergy Clin Immunol Glob, 2024,3（2）:100223. doi: 10.1016/j.jacig.2024.100223.
［12］	D'Apolito M, Santacroce R, Vazquez DO, et al. DAB2IP associates with hereditary angioedema: insights into the role of VEGF signaling in HAE pathophysiology［J］. J Allergy Clin Immunol, 2024,154（3）:698⁃706. doi: 10.1016/j.jaci.2024.05. 017.
［13］	Reshef A, Buttgereit T, Betschel SD, et al. Definition, acronyms, nomenclature, and classification of angioedema （DANCE）: AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus［J］. J Allergy Clin Immunol, 2024,154（2）:398⁃411.e1. doi: 10.1016/j.jaci.2024.03.024.
［14］	Giavina⁃Bianchi P, Aun MV, Kalil J. Vascular endothelial growth factor （VEGF） emerging as a mediator of hereditary angioedema （HAE）［J］. World Allergy Organ J, 2024,17（8）:100942. doi: 10.1016/j.waojou.2024.100942.
［15］	Magerl M, Sala⁃Cunill A, Weber⁃Chrysochoou C, et al. Could it be hereditary angioedema? Perspectives from different medical specialties［J］. Clin Transl Allergy, 2023,13（9）:e12297. doi: 10.1002/clt2.12297.
［16］	Bygum A. Hereditary angio⁃oedema for dermatologists［J］. Dermatology, 2019,235（4）:263⁃275. doi: 10.1159/000500196.
［17］	Mormile I, Palestra F, Petraroli A, et al. Neurologic and psychiatric manifestations of bradykinin⁃mediated angioedema: old and new challenges［J］. Int J Mol Sci, 2023,24（15）:12184. doi: 10.3390/ijms241512184.
［18］	Hsu FI, Lumry W, Riedl M, et al. Considerations in the management of hereditary angioedema due to C1⁃INH deficiency in women of childbearing age［J］. Allergy Asthma Clin Immunol, 2022,18（1）:64. doi: 10.1186/s13223⁃022⁃00689⁃9.
［19］	Martinez⁃Saguer I, Farkas H. Erythema marginatum as an early symptom of hereditary angioedema: case report of 2 newborns［J］. Pediatrics, 2016,137（2）:e20152411. doi: 10.1542/peds. 2015⁃2411.
［20］	Bork K, Meng G, Staubach P, et al. Hereditary angioedema: new findings concerning symptoms, affected organs, and course［J］. Am J Med, 2006,119（3）:267⁃274. doi: 10.1016/j.amjmed.2005. 09.064.
［21］	Kusuma A, Relan A, Knulst AC, et al. Clinical impact of peripheral attacks in hereditary angioedema patients［J］. Am J Med, 2012,125（9）:937.e17⁃e24. doi: 10.1016/j.amjmed.2011.12. 016.
［22］	Maurer M, Magerl M. Differences and similarities in the mechanisms and clinical expression of bradykinin⁃mediated vs. mast cell⁃mediated angioedema［J］. Clin Rev Allergy Immunol, 2021,61（1）:40⁃49. doi: 10.1007/s12016⁃021⁃08841⁃w.
［23］	Bork K, Hardt J, Schicketanz KH, et al. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency［J］. Arch Intern Med, 2003,163（10）:1229⁃1235. doi: 10.1001/archinte. 163.10.1229.
［24］	张抒扬. 罕见病诊疗指南（2019 年版）［M］. 北京: 人民卫生出版社, 2019.
［25］	Busse PJ, Christiansen SC, Riedl MA, et al. US HAEA Medical Advisory Board 2020 guidelines for the management of hereditary angioedema［J］. J Allergy Clin Immunol Pract, 2021,9（1）:132⁃150. doi: 10.1016/j.jaip.2020.08.046.
［26］	Manning ME. Hereditary angioedema: differential diagnosis, diagnostic tests, and family screening［J］. Allergy Asthma Proc, 2020,41（Suppl 1）:S22⁃S25. doi: 10.2500/aap.2020.41.200062.
［27］	Gil⁃Serrano J, Labrador⁃Horrillo M, Galvan⁃Blasco P, et al. Systemic inflammation biomarkers during angioedema attacks in hereditary angioedema［J］. Front Immunol, 2024,15:1400526. doi: 10.3389/fimmu.2024.1400526.
［28］	王林霞, 张立明, 史美慧, 等. 慢性自发性荨麻疹伴与不伴血管性水肿患者131例临床特征回顾分析［J］. 中华皮肤科杂志, 2024,57（6）:510⁃515. doi:10.35541/cjd.20230544.
［29］	Cicardi M, Aberer W, Banerji A, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group［J］. Allergy, 2014,69（5）:602⁃616. doi: 10.1111/all.12380.
［30］	Banerji A, Blumenthal KG, Lai KH, et al. Epidemiology of ACE inhibitor angioedema utilizing a large electronic health record［J］. J Allergy Clin Immunol Pract, 2017,5（3）:744⁃749. doi: 10.1016/j.jaip.2017.02.018.
［31］	Mormile I, Cocchiaro A, Bova M, et al. Gastrointestinal manifestations of angioedema: a potential area of misdiagnosis［J］. Eur J Gastroenterol Hepatol, 2021,33（6）:787⁃793. doi: 10.1097/MEG.0000000000001848.
［32］	Radojicic C. Guidelines for management of hereditary angioedema: what is new? what is missing?［J］. Allergy Asthma Proc, 2022,43（1）:12⁃19. doi: 10.2500/aap.2022.43.210086.
［33］	Can PK, Degi Rmentepe EN, Etikan P, et al. Assessment of disease activity and quality of life in patients with recurrent bradykinin⁃mediated versus mast cell⁃mediated angioedema［J］. World Allergy Organ J, 2021,14（7）:100554. doi: 10.1016/j.waojou.2021.100554.
［34］	Forjaz MJ, Ayala A, Caminoa M, et al. HAE⁃AS: a specific disease activity scale for hereditary angioedema with C1⁃inhibitor deficiency［J］. J Investig Allergol Clin Immunol, 2021,31（3）:246⁃252. doi: 10.18176/jiaci.0479.
［35］	Weller K, Donoso T, Magerl M, et al. Validation of the angioedema control test （AECT）⁃a patient⁃reported outcome instrument for assessing angioedema control［J］. J Allergy Clin Immunol Pract, 2020,8（6）:2050⁃2057. doi: 10.1016/j.jaip. 2020.02.038.
［36］	Kulthanan K, Chularojanamontri L, Rujitharanawong C, et al. Angioedema quality of life questionnaire （AE⁃QoL） ⁃ interpretability and sensitivity to change［J］. Health Qual Life Outcomes, 2019,17（1）:160. doi: 10.1186/s12955⁃019⁃1229⁃3.
［37］	Jean⁃Baptiste M, Itzler R, Prusty S, et al. The symptom experience of hereditary angioedema （HAE） patients beyond HAE attacks: literature review and clinician interviews［J］. Orphanet J Rare Dis, 2022,17（1）:232. doi: 10.1186/s13023⁃022⁃02360⁃3.
［38］	周宁, 韩小彤, 陈松, 等. 遗传性血管性水肿急诊科诊疗路径［J］. 中国急救医学, 2024,44（2）:99⁃105.
［39］	张凌凡, 赵宇晗, 李智慧, 等. 遗传性血管性水肿治疗药物的临床研究进展［J］. 世界临床药物, 2020,41（4）:319⁃322. doi: 10.13683/j.wph.2020.04.015.
［40］	Riedl MA, Maurer M, Bernstein JA, et al. Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks［J］. Allergy, 2020,75（11）:2879⁃2887. doi: 10.1111/all.14416.

[1]	中国儿童鲜红斑痣诊断和治疗专家共识制订专家组中国医师协会皮肤科医师分会儿童学组. [开放获取] 儿童鲜红斑痣诊疗专家共识（2025版）[J]. 中华皮肤科杂志, 2025, 58(5): 396-404.
[2]	中国中西医结合学会皮肤性病专业委员会皮肤肿瘤学组中国抗癌协会黑色素瘤专业委员会中国抗癌协会皮肤肿瘤整合康复专业委员会. [开放获取] 色素痣诊疗专家共识（2025版）[J]. 中华皮肤科杂志, 2025, 58(5): 387-395.
[3]	中华医学会皮肤性病学分会儿童学组中华医学会儿科学分会皮肤性病学组中国康复医学会皮肤病康复专业委员会中国医师协会皮肤科医师分会儿童皮肤病学组. [开放获取] 中国儿童特应性皮炎专病门诊建设及标准化病案管理专家共识（2025版）[J]. 中华皮肤科杂志, 2025, 0(4): 20240338-e20240338.
[4]	王伟霞王晨窦进法卞璐宋静卉李振鲁李建国王建波. 遗传性纤维性皮肤异色病伴跟腱挛缩、肌病和肺纤维化：病例报道及基因型与表型关系的文献回顾分析[J]. 中华皮肤科杂志, 2025, 58(4): 356-360.
[5]	中华医学会皮肤性病学分会中国医师协会皮肤科医师分会中国医疗保健国际交流促进会皮肤医学分会中国罕见病联盟皮肤罕见病专业委员会国家皮肤与免疫疾病临床医学研究中心. 【开放获取】副肿瘤性天疱疮诊疗中国专家共识（2025版）[J]. 中华皮肤科杂志, 2025, 58(4): 289-296.
[6]	中国医师协会皮肤科医师分会痤疮学组中国研究型医院学会皮肤科学专业委员会中国中西医结合学会皮肤性病专业委员会痤疮学组. [开放获取] 寻常痤疮临床严重度分级及疗效评价中国专家共识[J]. 中华皮肤科杂志, 2025, 0(4): 20250034-e20250034.
[7]	中国康复医学会皮肤病康复专业委员会中华医学会皮肤性病学分会中国医学装备协会皮肤病与皮肤美容分会光医学治疗装备学组. [开放获取] 红蓝黄光治疗皮肤病临床应用专家共识（2025版）[J]. 中华皮肤科杂志, 2025, 58(3): 209-215.
[8]	中国医学装备协会皮肤病与皮肤美容分会. 皮肤病靶向治疗专家共识（2025版） [J]. 中华皮肤科杂志, 2025, 58(2): 99-125.
[9]	中国中西医结合学会皮肤性病专业委员会中华医学会皮肤性病学分会中国医师协会皮肤科医师分会. 常见非黑素细胞性皮肤肿瘤的反射式共聚焦显微镜特征专家共识（2025版）[J]. 中华皮肤科杂志, 2025, 58(1): 20-33.
[10]	中国康复医学会皮肤病康复专业委员会中国中西医结合学会皮肤性病专业委员会老年皮肤病学组. [开放获取] 老年皮肤瘙痒症诊疗与康复专家共识（2025版）[J]. 中华皮肤科杂志, 2025, 58(1): 1-8.
[11]	中国康复医学会皮肤病康复专业委员会中国康复医学会光动力治疗与康复专业委员会中华医学会皮肤性病学分会光动力治疗协作组. [开放获取] 氨基酮戊酸光动力疗法治疗非黑色素瘤皮肤癌临床应用专家共识（2025版）[J]. 中华皮肤科杂志, 2025, 58(1): 9-19.
[12]	中国中西医结合学会皮肤性病专业委员会中华医学会皮肤性病学分会中国医师协会皮肤科医师分会. 反射式共聚焦显微镜在常见黑素细胞性皮肤肿瘤中的应用专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(9): 775-784.
[13]	海姆泊芬光动力疗法治疗鲜红斑痣共识制订专家组. [开放获取] 海姆泊芬光动力疗法治疗鲜红斑痣专家共识（2024）[J]. 中华皮肤科杂志, 2024, 57(7): 581-589.
[14]	王晨薛晨红宋静卉李建国李振鲁张守民李明王建波. 阿达木单抗治疗Blau综合征1家系3例[J]. 中华皮肤科杂志, 2024, 57(6): 553-556.
[15]	中华医学会皮肤性病学分会中国康复医学会皮肤性病学分会中国医师协会皮肤科医师分会. [开放获取] 过敏原特异性IgE检测在特应性皮炎中的临床应用专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(6): 493-502.

遗传性血管性水肿诊疗路径皮肤科专家共识（2025版）

Recommendations for the diagnosis and treatment pathway for hereditary angioedema:a dermatology expert group consensus （2025 edition）

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 40

相关文章 15

Metrics

本文评价

推荐阅读 10